SEC Form 4 · accession 0001144204-15-024299
VACCINOGEN INC · VGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew Tussing
Officer — See Remarks · Director
Period of report
Apr 20, 2015
Accepted (ET)
Apr 22, 2015 · 4:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001453001
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Apr 20, 2015 | A | 716,291 | $0.00 | A | 1,116,718 | D | |
| Common stock | Apr 20, 2015 | A | 61,432 | $0.00 | A | 1,178,150 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee stock option (right to buy) | $5.50 | Apr 20, 2015 | A | 1,493,374 | A | Apr 20, 2015 | Apr 20, 2025 | Common stock | 1,493,374 | 1,493,374 | D |
Remarks
Officer Title- CEO, acting CFO, Treasurer and Secretary--Exhibit List: Exhibit 24-Power of Attorney